New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
06:57 EDTZFGNZafgen initiated with an Outperform at JMP Securities
Target $31.
News For ZFGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 11, 2014
16:11 EDTZFGNZafgen reports Q3 EPS (65c), consensus (87c)
As a result of increased clarity related to the timing of certain pre-clinical and clinical expenses, the company now expects to end 2014 with greater than $100M in cash and cash equivalents, as compared to the previous estimate of greater than $95M. "We are pleased to increase our cash guidance at the end of calendar year 2014 to greater than $100M from $95M in cash and cash equivalents," said Patricia Allen, Chief Financial Officer of Zafgen. "We believe this financial position enables us to continue to grow our business, including executing on and obtaining clinical data from three clinical trials we will be conducting in 2014 and 2015."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use